Longer Reproductive Spans Linked to Younger Brains in Women

This article discusses a significant study examining the relationship between reproductive spans and brain health in women. Conducted on over a thousand postmenopausal women, the research employed brain MRIs as biomarkers to assess cognitive aging relative to chronological age [1].

Linking Sex Hormones to Brain Health

The female reproductive system typically begins to decline earlier than other body systems, adversely affecting the aging process of various organs, including the brain. Notably, the risk of developing dementia increases around the time of menopause [2].

Changes in the levels of female sex hormones, primarily estradiol, are critical during this process. Estradiol levels rise before menarche and peak until the onset of perimenopause, after which they decrease significantly throughout menopause and into postmenopause. The study hypothesis states that a decrease in estradiol levels may correlate with the development of dementia and other age-related neuropathologies in women.

Animal studies support this hypothesis, illustrating estradiol's role in promoting brain health through mechanisms such as:

  • Synaptic plasticity
  • Neurogenesis enhancement
  • Protection against oxidative stress and neuroinflammation [3]

While some human studies indicate menarche and menopause timing as critical risk factors for dementia, the definitive link between brain health and estradiol levels remains to be fully established.

The Age of the Brain

To gauge brain age, this study utilized structural magnetic resonance imaging (MRI) scans on 1,006 postmenopausal women, taking an initial scan followed by a follow-up around two years later. Researchers assessed brain age to establish BrainAGE, defined as the difference between estimated brain age and the participant's chronological age.

Longer Reproductive Span, Younger Brain

Through cross-sectional and longitudinal analyses, researchers uncovered associations between reproductive span, age at menarche, age at menopause, and BrainAGE. Key findings include:

  1. A notable negative correlation between BrainAGE and reproductive span, suggesting that women with extended reproductive spans possess younger brains.
  2. A negative association between BrainAGE and age at menopause, indicating that for each additional year older at menopause, brain age appeared 0.1 years younger in the cross-sectional study.
  3. A strong positive correlation between BrainAGE and age at menarche, suggesting each year earlier at menarche corresponds to a brain that is 0.32 years younger in the cross-sectional assessment.

Even after controlling for variables like number of live births, hormone replacement therapy, and various lifestyle factors, the results remained statistically significant.

The Window of Opportunity

Researchers highlight how the study's findings bolster the emerging notion of a 'window of opportunity' regarding hormone replacement therapy during menopause to mitigate dementia risks. "These findings support the idea that estradiol ... may help protect the brain as it ages,” stated Associate Professor Eileen Lueders from the University of Auckland’s School of Psychology.

Alicja Nowacka, a Ph.D. student at the same institution, noted, “As more women weigh the benefits of hormone therapy during menopause, findings like these spark important conversations about women's brain health.”

Expanding the Research

Despite the relevance of the findings, the study calls for further investigation due to certain limitations, including a relatively homogeneous sample lacking in ethnic and socio-economic diversity. Additionally, while correlations with hormonal changes were identified, the researchers did not directly measure estradiol levels.

Future research should focus on the complex interplay between brain health and estradiol, incorporating lifestyle choices and genetic factors that may influence cognitive aging.

Literature Cited

[1] Luders, E., Poromaa, I. S., Barth, C., & Gaser, C. (2025). A Case for estradiol: younger brains in women with earlier menarche and later menopause. GigaScience, 14, giaf060.

[2] Mosconi, L., Rahman, A., Diaz, I., Wu, X., Scheyer, O., Hristov, H. W., et al. (2018). Increased Alzheimer’s risk during the menopause transition: A 3-year longitudinal brain imaging study. PloS one, 13(12), e0207885.

[3] Vegeto, E., Benedusi, V., & Maggi, A. (2008). Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Frontiers in neuroendocrinology, 29(4), 507–519.

[4] Behl, C., Widmann, M., Trapp, T., & Holsboer, F. (1995). 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochemical and biophysical research communications, 216(2), 473–482.

[5] Tanapat, P., Hastings, N. B., Reeves, A. J., & Gould, E. (1999). Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. The Journal of neuroscience: the official journal of the Society for Neuroscience, 19(14), 5792–5801.

[6] Xiong, J., et al. (2022). FSH blockade improves cognition in mice with Alzheimer’s disease. Nature, 603(7901), 470–476.

[7] Mishra, A., & Brinton, R. D. (2018). Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease. Frontiers in aging neuroscience, 10, 312.